Geneos Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$747K Sell
15,502
-491
-3% -$22.9K 0.02% 579
2025
Q4
$775K Buy
15,993
+1,924
+14% +$95.4K 0.02% 561
2025
Q3
$664K Sell
14,069
-1,869
-12% -$90.2K 0.02% 580
2025
Q2
$770K Sell
15,938
-10,847
-40% -$554K 0.02% 595
2025
Q1
$1.49M Buy
26,785
+16,562
+162% +$896K 0.02% 557
2024
Q4
$493K Sell
10,223
-219
-2% -$11.1K 0.02% 595
2024
Q3
$602K Buy
10,442
+2,014
+24% +$109K 0.02% 511
2024
Q2
$409K Buy
8,428
+1,365
+19% +$65.8K 0.02% 544
2024
Q1
$343K Buy
7,063
+582
+9% +$28.4K 0.02% 572
2023
Q4
$322K Buy
6,481
+1,902
+42% +$93K 0.02% 561
2023
Q3
$246K Buy
4,579
+124
+3% +$6.61K 0.01% 630
2023
Q2
$240K Buy
4,455
+936
+27% +$50.4K 0.01% 639
2023
Q1
$192K Sell
3,519
-397
-10% -$19.3K 0.01% 659
2022
Q4
$190K Sell
3,916
-368
-9% -$16.2K 0.01% 635
2022
Q3
$162K Sell
4,284
-1,901
-31% -$84.7K 0.01% 662
2022
Q2
$315K Buy
6,185
+24
+0.4% +$1.27K 0.02% 614
2022
Q1
$316K Sell
6,161
-151
-2% -$7.8K 0.01% 650
2021
Q4
$316K Buy
6,312
+91
+1% +$4.5K 0.01% 718
2021
Q3
$298K Buy
6,221
+141
+2% +$7.17K 0.01% 716
2021
Q2
$318K Buy
6,080
+106
+2% +$5.53K 0.01% 671
2021
Q1
$312K Sell
5,974
-9
-0.2% -$432 0.01% 781
2020
Q4
$293K Buy
5,983
+312
+6% +$15.4K 0.01% 697
2020
Q3
$287K Buy
5,671
+92
+2% +$4.74K 0.01% 572
2020
Q2
$284K Buy
5,579
+541
+11% +$26.3K 0.02% 563
2020
Q1
$213K Buy
5,038
+1,813
+56% +$86.7K 0.01% 592
2019
Q4
$164K Buy
3,225
+544
+20% +$25.5K 0.01% 772
2019
Q3
$124K Buy
2,681
+40
+2% +$1.73K 0.01% 820
2019
Q2
$117K Buy
2,641
+116
+5% +$4.93K 0.01% 850
2019
Q1
$111K Buy
2,525
+516
+26% +$22.1K 0.01% 828
2018
Q4
$86K Sell
2,009
-183
-8% -$8.07K 0.01% 889
2018
Q3
$97K Sell
2,192
-1,585
-42% -$67.7K 0.01% 894
2018
Q2
$151K Sell
3,777
-87
-2% -$3.42K 0.01% 649
2018
Q1
$154K Buy
3,864
+159
+4% +$6.62K 0.01% 610
2017
Q4
$159K Buy
3,705
+204
+6% +$9.41K 0.01% 600
2017
Q3
$174K Buy
3,501
+909
+35% +$44K 0.02% 552
2017
Q2
$124K Buy
2,592
+456
+21% +$21.8K 0.01% 627
2017
Q1
$96K Sell
2,136
-485
-19% -$20.6K 0.01% 672
2016
Q4
$106K Buy
2,621
+39
+2% +$1.54K 0.01% 603
2016
Q3
$98K Sell
2,582
-99
-4% -$3.97K 0.01% 606
2016
Q2
$112K Sell
2,681
-138
-5% -$5.66K 0.02% 563
2016
Q1
$113K Buy
+2,819
New +$113K 0.02% 550

Other funds holding SNY

Geneos Wealth Management's SNY Position: Q1 2026 in Review

Geneos Wealth Management reduced its Sanofi (SNY) stake by 3.1% in Q1 2026, selling an estimated $22.9K and leaving 15,502 shares worth $747K. The position accounts for 0.02% of the portfolio, ranked #579.

Geneos Wealth Management first reported a position in SNY in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.49M in Q1 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Geneos Wealth Management held 15,502 shares of Sanofi worth $747K as of Q1 2026.
  • Geneos Wealth Management sold 491 Sanofi shares in Q1 2026, an estimated $22.9K.
  • Sanofi made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #579 holding.
  • Geneos Wealth Management first reported a position in Sanofi in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Sanofi position peaked at $1.49M in Q1 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.